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Efflux of cyclic nucleotides via active transport in many
cell types has been documented for many decades. How-
ever, the only route of cyclic nucleotide breakdown is via
the action of specific phosphodiesterases (PDEs). The
mammalian cGMP-specific phosphodiesterase, PDE6,
was established as a retinal-specific enzyme. By contrast,
the close Drosophila PDE6 homologue is functionally
expressed in Drosophila Malpighian (renal) tubules. Gen-
eration of transgenic Drosophila allowing targeted expres-
sion of tagged PDE6 to tubule Type I (principal) cells
revealed localisation of PDE6 primarily at the apical
membranes. As expected, such targeted over-expression of
PDE6 resulted in elevated cGMP-PDE activity and in
decreased cGMP content. Significantly, over-expression of
PDE6 inhibits active transport and efflux of cGMP by
tubules. This effect is specific to PDE6 action, as no effect
on cGMP transport is observed in tubules from a bovine
PDE5 transgenic line. Specific ablation of PDE6 via
expression of a targeted PDE6 RNAi transgene in tubule
principal cells results in significantly increased active
transport of cGMP, thus proving a direct, cell-specific role
for PDE6 in cGMP transport. Finally, pharmacological
inhibition of PDE6 in wild-type tubules using the verte-
brate cG-PDE inhibitor, Zaprinast, also results in stimu-
lated cGMP transport. We provide the first demonstration
of a novel role for non-retinal PDE6 in regulating cGMP
transport and efflux in a fluid-transporting epithelium.
from 2nd International Conference of cGMP Generators, Effectors and Therapeutic Implications
Potsdam, Germany, 10–12 June, 2005
Published: 16 June 2005
BMC Pharmacology 2005, 5(Suppl 1):P11 doi:10.1186/1471-2210-5-S1-P11
<supplement> <title> <p>2nd International Conference of cGMP Generators, Effectors and Therapeutic Implications</p> </title> <note>Meeting abstracts</note> </supplement>
